These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22073763)

  • 41. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
    Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
    J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular diseases among patients with schizophrenia.
    Azad MC; Shoesmith WD; Al Mamun M; Abdullah AF; Naing DK; Phanindranath M; Turin TC
    Asian J Psychiatr; 2016 Feb; 19():28-36. PubMed ID: 26957335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder.
    Tan XW; Seow E; Abdin E; Verma S; Sim K; Chong SA; Subramaniam M
    BMC Psychiatry; 2019 Sep; 19(1):267. PubMed ID: 31477079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychiatric readmissions and their association with physical comorbidity: a systematic literature review.
    Šprah L; Dernovšek MZ; Wahlbeck K; Haaramo P
    BMC Psychiatry; 2017 Jan; 17(1):2. PubMed ID: 28049441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Old patients suffering from long-standing schizophrenia: clinical aspects].
    Jalenques I; Rachez C; Tourtauchaux R; Cellier Y; Legrand G
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Sep; 9(3):345-53. PubMed ID: 21896437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of antipsychotic medication on metabolic syndrome.
    Jones M; Jones A
    Nurs Stand; 2008 Aug 6-12; 22(48):43-8. PubMed ID: 18727355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The paradox of premature mortality in schizophrenia: new research questions.
    Wildgust HJ; Hodgson R; Beary M
    J Psychopharmacol; 2010 Nov; 24(4 Suppl):9-15. PubMed ID: 20923916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical comorbidity in schizophrenia.
    Jeste DV; Gladsjo JA; Lindamer LA; Lacro JP
    Schizophr Bull; 1996; 22(3):413-30. PubMed ID: 8873293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Why do schizophrenic patients die sooner?].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Jun; 151(24):17. PubMed ID: 19645193
    [No Abstract]   [Full Text] [Related]  

  • 50. Cognition and aging in psychopathology: focus on schizophrenia and depression.
    Harvey PD; Reichenberg A; Bowie CR
    Annu Rev Clin Psychol; 2006; 2():389-409. PubMed ID: 17716076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical co-morbidity risk factors and barriers to care for people with schizophrenia.
    Muir-Cochrane E
    J Psychiatr Ment Health Nurs; 2006 Aug; 13(4):447-52. PubMed ID: 16867129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Older people with chronic schizophrenia.
    Karim S; Overshott R; Burns A
    Aging Ment Health; 2005 Jul; 9(4):315-24. PubMed ID: 16019287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of severe mental illness on survival of people with diabetes.
    Vinogradova Y; Coupland C; Hippisley-Cox J; Whyte S; Penny C
    Br J Psychiatry; 2010 Oct; 197(4):272-7. PubMed ID: 20884949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
    McIntyre RS
    J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sport as applied therapy in patients with schizophrenic psychoses].
    Ewers SM; Claussen MC
    Ther Umsch; 2018 Jun; 75(1):77-80. PubMed ID: 29909767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The social and economic burden of treatment-resistant schizophrenia: a systematic literature review.
    Kennedy JL; Altar CA; Taylor DL; Degtiar I; Hornberger JC
    Int Clin Psychopharmacol; 2014 Mar; 29(2):63-76. PubMed ID: 23995856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mental health multimorbidity and poor quality of life in patients with schizophrenia.
    Bhalla IP; Stefanovics EA; Rosenheck RA
    Schizophr Res; 2018 Nov; 201():39-45. PubMed ID: 29709490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mortality in schizophrenic patients. 3 years follow-up of a cohort].
    Casadebaig F; Philippe A
    Encephale; 1999; 25(4):329-37. PubMed ID: 10546089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.
    Adan A; Marquez-Arrico JE; Gilchrist G
    Health Qual Life Outcomes; 2017 Oct; 15(1):209. PubMed ID: 29061151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.